Newsfeeds Archive - Spark Newswire

1 minute read

Revolution Medicines And EQRx Stockholders Approve EQRx Acquisition

November 8, 12:33 PM

Revolution Medicines, Inc. (NASDAQ:RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. (NASDAQ:EQRX), announced that earlier today, at their respective special

EQRX

5 minute read

Why Aaron’s Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

August 1, 3:05 PM

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

AAN

3 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

August 1, 1:31 PM

Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares increased by 170.2% to $3.86 during Tuesday’s regular session. The current volume of…

ABVC

1 minute read

Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital

By Vandana Singh

August 1, 12:52 PM

Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to

EQRX

2 minute read

Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday

By Lisa Levin

August 1, 11:33 AM

U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC) jumped 49% to $15.03 amid claims of a new superconductor from a group of physicists.

AMSC

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

August 1, 9:06 AM

Gainers ABVC BioPharma (NASDAQ:ABVC) shares moved upwards by 92.0% to $4.78 during Tuesday’s pre-market session. The market value…

ABVC

2 minute read

M&A
News

Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction

By Charles Gross

August 1, 7:12 AM

Revolution Medicines, Inc. ("Revolution Medicines" or the "Company") (NASDAQ:RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc.

EQRX